More on B-cell-depleting induction therapy and acute cellular rejection.
Tydén
Gunnar
G
Mjörnstedt
Lars
L
Ekberg
Henrik
H
D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes; D006084:Graft Rejection / Q000276:immunology; D006801:Humans; D008212:Lymphocyte Depletion; D016032:Randomized Controlled Trials as Topic; D000069283:Rituximab; D019172:Transplantation Conditioning; D014181:Transplantation Immunology
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab